Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments.

Suseelan, Shayam; Pinna, Graziano

Suseelan, Shayam; Pinna, Graziano.

Afiliación

Suseelan S; The Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States.
Pinna G; The Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States; UI Center on Depression and Resilience (UICDR), Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States; Center for Alcohol Research in Epigenetics, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, United States. Electronic address: gpinna@uic.edu.

Adv Clin Chem ; 112: 1-67, 2023.

Article en En | MEDLINE | ID: mdl-36642481

Asunto(s)

Trastorno Depresivo Mayor; Humanos; Trastorno Depresivo Mayor/diagnóstico; Trastorno Depresivo Mayor/metabolismo; Metilación de ADN; Biomarcadores/metabolismo; Proteómica; Metabolómica

Palabras clave

Animal models; Biomarkers; Endocannabinoids; Epigenetics; Major depressive disorder; Mood disorders; Neurosteroids; Neurotropic factors

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Adv Clin Chem Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google